Osaic Holdings
PHIO icon

Osaic Holdings’s Phio Pharmaceuticals PHIO Stock Holding History

Osaic Holdings’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06K Hold
2,000
– – ﹤0.01% 7267
2026
Q1 		$2.44K Buy
+2,000
New +$2.28K ﹤0.01% 6981

Other funds holding PHIO

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Osaic Holdings's PHIO Position: Q2 2026 in Review

Osaic Holdings held its Phio Pharmaceuticals (PHIO) position steady in Q2 2026 at 2,000 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #7267.

Osaic Holdings first reported a position in PHIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.44K in Q1 2026. 24 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.

  • Osaic Holdings held 2,000 shares of Phio Pharmaceuticals worth $2.06K as of Q2 2026.
  • Osaic Holdings left its Phio Pharmaceuticals share count unchanged in Q2 2026.
  • Phio Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7267 holding.
  • Osaic Holdings first reported a position in Phio Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Osaic Holdings's Phio Pharmaceuticals position peaked at $2.44K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.